Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Apr 6;9(1):21.
doi: 10.1038/s41523-023-00518-1.

Biological insights and novel biomarker discovery through deep learning approaches in breast cancer histopathology

Affiliations
Review

Biological insights and novel biomarker discovery through deep learning approaches in breast cancer histopathology

Divneet Mandair et al. NPJ Breast Cancer. .

Abstract

Breast cancer remains a highly prevalent disease with considerable inter- and intra-tumoral heterogeneity complicating prognostication and treatment decisions. The utilization and depth of genomic, transcriptomic and proteomic data for cancer has exploded over recent times and the addition of spatial context to this information, by understanding the correlating morphologic and spatial patterns of cells in tissue samples, has created an exciting frontier of research, histo-genomics. At the same time, deep learning (DL), a class of machine learning algorithms employing artificial neural networks, has rapidly progressed in the last decade with a confluence of technical developments - including the advent of modern graphic processing units (GPU), allowing efficient implementation of increasingly complex architectures at scale; advances in the theoretical and practical design of network architectures; and access to larger datasets for training - all leading to sweeping advances in image classification and object detection. In this review, we examine recent developments in the application of DL in breast cancer histology with particular emphasis of those producing biologic insights or novel biomarkers, spanning the extraction of genomic information to the use of stroma to predict cancer recurrence, with the aim of suggesting avenues for further advancing this exciting field.

PubMed Disclaimer

Conflict of interest statement

Directly related to the work included in the manuscript: JSR-F reports membership of the scientific advisory board of Paige.AI and receiving personal/consultancy fees and stock options from Paige.AI. AA reports membership of the SAB and stock ownership of Trial Library. Outside the scope of the work included in the manuscript: JSR-F reports receiving consultancy fees from Goldman Sachs, REPARE Therapeutics and Personalis, membership of the scientific advisory boards of VolitionRx, REPARE Therapeutics and Personalis, membership of the Board of Directors of Grupo Oncoclinicas, and ad hoc membership of the scientific advisory boards of Roche Tissue Diagnostics, Ventana Medical Systems, AstraZeneca, Daiichi Sankyo and MSD. AA reports he is the Co-Founder of Tango, Azkarra, OviBio, Kytarro. SAB Member: Genentech, GLAdiator, Cura, Circle, Bluestar, Earli, GSK, Ambagon, PhoenixMD, Yingli, ProLynx. Board Member: Cambridge Science Corp., Cytomx. Grant/Research support from: SPARC, AstraZeneca. He holds patents on the use of PARP inhibitors held jointly with AstraZeneca from which he has benefitted financially (and may do so in the future).

Figures

Fig. 1
Fig. 1. Example neural network architectures.
a Basic neural network demonstrating input nodes with dimensionality of 8, two hidden layers that involve dimension expansion and subsequent reduction with a final output node. Each input node is connected to each of the hidden nodes (a fully connected network), with lines connecting nodes representing weights applied to a source to reach a destination. The above representation can also be visualized as a weight matrix, translating from the dimensionality of the input nodes to the dimensionality of the output nodes. b A pictorial the training process – inputs are fed to a DL network, predictions are made and compared to ground truth labels and parameters are updated in a loop. c A convolutional network architecture demonstrating the typical backbone of pooling layers followed by convolutional layers. Note that convolutions increase the number of filters while reducing dimensionality in the x/y dimensions (https://alexlenail.me/NN-SVG/).
Fig. 2
Fig. 2. Image tasks in computer vision.
Examples of (a) image classification, in which the task is one of classifying an image as one of 4 different types of animals (b) object detection, in which not only are objects classified but also identified in the image with boxes around their respective location and (c) image segmentation, where every pixel in the image is translated into some label, here the vessels, airways and contours of a lung. Sources: (a) the author’s photographs of dog (DM) and Jonesy the cat (AA). b https://commons.wikimedia.org/wiki/File:Detected-with-YOLO--Schreibtisch-mit-Objekten.jpg (c) https://commons.wikimedia.org/wiki/File:3D_CT_of_thorax.jpg.
Fig. 3
Fig. 3. Deep learning features from WSI.
Categories of features extracted from deep learning systems in breast cancer are illustrated, including invasive carcinoma architecture, cellular makeup of the microenvironment, nuclei features (including segmentation, orientation and nucleoli prominence), and stroma characteristics including collagen fiber orientation. On the right, references of studies exploring the detection of the different categories of features.

Similar articles

Cited by

References

    1. Fitzgerald J, et al. Future of biomarker evaluation in the realm of artificial intelligence algorithms: application in improved therapeutic stratification of patients with breast and prostate cancer. J. Clin. Pathol. 2021;74:429–434. doi: 10.1136/jclinpath-2020-207351. - DOI - PubMed
    1. Barsoum I, Tawedrous E, Faragalla H, Yousef GM. Histo-genomics: digital pathology at the forefront of precision medicine. Acta Radiol. Diagn. 2019;6:203–212. - PubMed
    1. Campanella G, et al. Clinical-grade computational pathology using weakly supervised deep learning on whole slide images. Nat. Med. 2019;25:1301–1309. doi: 10.1038/s41591-019-0508-1. - DOI - PMC - PubMed
    1. Tran WT, et al. Personalized breast cancer treatments using artificial intelligence in radiomics and pathomics. J. Med Imaging Radiat. Sci. 2019;50:S32–s41. doi: 10.1016/j.jmir.2019.07.010. - DOI - PubMed
    1. LeCun Y, Bengio Y, Hinton G. Deep learning. Nature. 2015;521:436–444. doi: 10.1038/nature14539. - DOI - PubMed